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out, should give a better evaluation of its diagnostic and therapeutic value in
patients who are to undergo biliary surgery.
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DOES METOCLOPRAMIDE REDUCE VARICEAL
PRESSURE?
ABSTRACT
Kleber, G., Sauerbruch, T., Fischer, G., Geigenberger, G., Paumgartner, G. (1991)
Reduction of transmural oesophageal variceal pressure by metoclopramide. Journal
of Hepatology; 12: 362-366.
In nineteen patients with portal hypertension and oesophageal varices, transmural
variceal blood pressure was determined endoscopically by direct puncture of the
varices before and after intravenous administration of 20 mg metoclopramide or
placebo. No change in pressure was observed after placebo (mean difference -1.3 __.
24.5%, N.S.), however, metociopramide reduced the pressure by 17.6 _+ 18.6% (p
0.02). Our results suggest that metociopramide may be beneficial for the
prevention of treatment of variceal haemorrhage.HPB INTERNATIONAL 281
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This paper reports a study of 19 patients who had portal hypertension with
oesophageal varices and in whom transmural variceal pressure was assessed. This
was measured before and after intravenous administration of Metoclopramide or
placebo.
The idea of pharmacological manipulation of the lower oesophageal sphincter in
patients with portal hypertension is not new. In 1978, Miskowik suggested that the
lower oesophageal sphincter affected blood flow in the submucosal oesophageal
varices1.
It seems reasonable from anatomical studies that manipulation of the lower
oesophageal sphincter could affect the blood flow in distal oesophageal varices. The
detailed anatomy of the lower oesophageal veins was first described by Butler in
19512. However, one of the most imP3ortant pieces of anatomical work came from
Brazil with the study of de Carvalho. He first drew attention to the fact that the
veins in the distal part of the oesophagus, namely those veins lying near the
oesophago-gastric junction and therefore near the oesophageal sphincter, seem to
lie superficially, whereas the veins in the stomach and the veins in the more
proximal oesophagus tended to lie more deeply in the submucosa. During the past
decade several complementary anatomical investigations using modern techniques
have been published. A computer assisted image analysis study showed that the
veins in the distal oesophagus were lying superficially in the lamina propria,
whereas in the stomach and in the proximal oesophagus the veins lay chiefly in the
submucosa4.
This anatomical work proposed that the distal oesophagus (2cm to 5cm) is the
vulnerable area where varices are more prone to ruptures. Subsequent complemen-
tary studies have been published demonstrating a constant perforating vein at 36cm
using Doppler ultrasound. This further indicated that the lower oesophageal
sphincter in association with the local venous anatomy may have a role to play in
the pathogenesis of the site of variceal rupture6.
A study in Japan has confirmed the superficial nature of the veins in the distal
oesophagus. Further anatomical studies from Capetown described four layers of
veins in the oesophagus (1) intraepithelial vascular channels; (2) superficial venous
plexus; (3) deep venous plexus and (4) extrinsic veins which communicated with the
stomach veins8.
Studies from King’s College Hospital have also looked at the venous anatomy in
the lower oesophagus, using resin casting, and the authors have described four
zones: (a) gastric zone with veins in a longitudinal venous distribution; (b) palisade
zone with parallel vessels mainly in the lamina propria; (c) perforating zone with
"treble clef" veins and finally (d) a truncal zone with deep veins9. Further work
from Japan
1 has described findings similar to those of the King’s College Group.
It therefore seems clear that the critical area of rupture of varices appears to be
the lower 2cm to 5cm of the oesophagus and this may be related to the now well
described anatomical features of the venous drainage of this area which teleologi-
cally may be related to the presence of the lower oesophageal sphincter
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Fifteen years ago Cohen and his colleagues showed that metoclopramide gave a
dose-related increase in the lower oesophageal pressure both in response to oral
and intravenous administration of the drug12. However, it should be noted that the
accepted oral dose at that time was 10mg and this gave only a slight increase in the
lower oesophageal pressure which was not consistent in all of their patients.
Subsequently the Danish group in a very small series of patients (6) and using a
rather crude technique of measuring blood flow showed that metoclopramide
decreased the flow to the varices in five patients, and they related this to the
increase in the lower oesophageal sphincter pressure produced by the drug13.
Subsequently Lunderquist, using percutaneous transhepatic portography in
patients with portal hypertension and oesophageal varices showed that a number of
drugs could decrease variceal blood flow through the lower oesophagus. Although
the number of patients was very small the group showed that vasopressin did not
change the variceal blood flow. However, pentagastrin, presumably with its effect
of increasing the lower oesophageal sphincter pressure, interrupted the blood flow,
through the varices, in four of eight patientsTM.
In studies using azygos blood flow measurements in a small group of six patients
from Lebrec’s group, while an increase in lower oesophageal sphincter pressure
induced by domperidone was found, azygos blood was unaltered15. However, in a
larger series of patients contrary data from the Barcelona group has been pub-
lished. In 33 patients with azygos venous blood flow measurements the administ-
ration of both metoclopramide and domperidone caused a significant reduction in
azygos blood flow, compared to a placebo group. The authors concluded that this
was a local effect of the drugs in increasing the lower oesophageal sphincter
pressure as all the other parameters of portal pressure, hepatic blood flow and
cardiac output remained unaltered16.
Transmural oesophageal variceal pressure has been shown to be easily measured
by direct puncture of oesophageal varices17. Subsequently, the Sheffield group
showed that pharmacological constriction of the lower oesophageal sphincter did
reduce intravariceal pressure from a mean of 23mm Hg to 4mm Hg and these data
were significant. In a subsequent small trial in Egyptian patients who were actively
bleeding from varices in the lower 2cm of the oesophagus there appeared to be
benefit in giving metoclopramide TM.
The current paper from Munich shows that 20mg of intravenous metoclopramide
significantly reduced intravariceal pressure, compared to a placebo. The two
groups in the study were comparable but nonetheless of a total of 50 patients being
entered into the study, 31 of these had to be excluded, mainly because of
unsatisfactory pressure recordings. Some of these unsatisfactory recordings were
due to the varices being small and therefore difficulty may have occurred in
inserting the needle into the varix. This could alter the results as it has been well
shown that the larger varices tend to bleed more than smaller ones19. Furthermore,
the numbers in the study were relatively small with ten and nine in each group. In
addition, there were two patients, one in each group, who appeared to sustain a
remarkably large drop in pressure and again this could alter the results.
Nonetheless, the data from the paper under review and that of other data in the
literature indicate that overall there is probably a reduction in intravariceal
pressure by metoclopramide. However, although the data show a reduction in
intravariceal pressure with metoclopramide whether or not this can be translated
into clinical benefit is currently unclear.HPB INTERNATIONAL 283
A further study from the Barcelona group has shown no benefit with either
domperidone or metoclopramide given intravenously in patients who have had
bleeding from oesophageal varices. In a controlled study there is no difference in
re-bleeding rate compared to a placebo group, although the criteria for diagnosing
re-bleeding from the varices in this study could be criticised2.
In summary it seems likely that increasing the lower oesophageal sphincter
pressure by drugs such as metoclopramide increases the in-flow resistance into the
varices and may shift the collateral blood flow into the peri-oesophageal veins21.
There is therefore a sound anatomical and physiological basis for this hypothesis
but further clinical controlled trials are required.
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SOMATOSTATIN FOR BLEEDING OESOPHAGITIS
OR ULCERATION AFTER SCLEROTHERAPY FOR
OESOPHAGEAL VARICES
ABSTRACT
Jenkins, S.A., Shields, R., Jaser, N., Ellenbogen, S., Makin, C., Naylor, E.,
Newstead, M., Baxter, J.N. (1991) The Management of gastrointestinal haemorr-
hage by somatostatin after apparently successful endoscopic injection sclerotherapy
for bleeding oesophageal varices. Journal of Hepatology; 12: 296-301.
Twenty-two patients who experienced a severe haemorrhage from either oesophagi-
tis (n 8) or ulcers (n 14) following injection sclerotherapy of their oesophageal
varices were treated with intravenous administration of somatostatin (250 g/h).
Somatostatin was effective in controlling haemorrhage and preventing rebleeding in
all eight patients bleeding from oesophagitis and in 12 of the 14 patients bleeding
from oesophageal ulcers. In two patients with ulcers, haemorrhage persisted despite
two periods of concominant balloon tamponade and somatostatin infusion and
bleeding was eventually controlled by repeated hourly bolus injections of the
hormone for 24 h superimposed on the continuous infusion. The results of this study
suggest that somatostatin is an effective and safe treatment for the control of
bleeding from either oesophagitis or ulcers following injection sclerotherapy of
oesophageal varices.